Ruslami Rovina

Prof. Rovina Ruslami, MD, PhD, is a professor of pharmacology at the Universitas Padjadjaran, Bandung, Indonesia. Having completed her PhD in clinical pharmacology, she continues doing research focusing on how we can optimize TB treatment—particularly through high-dose rifampicin—to improve patient outcomes. For her works in the field of global health, she received national and international recognition: the Habibie Award from the Habibie Center, Indonesia, and the Christiaan Eijkman Award from the KIT, The Netherlands.

Job Title

Academic Staff, Researcher

Faculty / Department / Division

Dept. of Biomedical Sciences

Institution / Organisation

Faculty of Medicine, Universitas padjadjaran

22 November 2026, Sunday

Time	Session

09:00 10:30	S29: The Continuum of TB Care Pang Yong Kek Chairperson Malaysia Optimised Case Finding Strategies Bornali Datta Speaker India Managing Dual Epidemics: TB and DM Ruslami Rovina Speaker Indonesia "Tuberculosis (TB) and Diabetes Mellitus (DM) are well known to have a bidirectional relationship since a long time ago. DM increases the risk of having TB and vice versa; TB will worsen the clinical manifestation of DM. There is a pathophysiology link between these two epidemics. Therefore, TB and DM will increasingly present together. There is a need to have a strategy on how we can effectively screen and diagnose TB and DM. With regard to the treatment management, this is important yet challenging. This presentation will discuss the management of TB and DM when they appear together." Life after TB: A Review of Post-TB Lung Diseases Neranjan Dissanayake Speaker Sri Lanka Q&A Ballroom 3, Lower Ground Floor

Time

Session

09:00

10:30

S29: The Continuum of TB Care

Pang Yong Kek Chairperson Malaysia

Optimised Case Finding Strategies

Bornali Datta Speaker India
Managing Dual Epidemics: TB and DM

Ruslami Rovina Speaker Indonesia

"Tuberculosis (TB) and Diabetes Mellitus (DM) are well known to have a bidirectional relationship since a long time ago. DM increases the risk of having TB and vice versa; TB will worsen the clinical manifestation of DM. There is a pathophysiology link between these two epidemics. Therefore, TB and DM will increasingly present together. There is a need to have a strategy on how we can effectively screen and diagnose TB and DM. With regard to the treatment management, this is important yet challenging. This presentation will discuss the management of TB and DM when they appear together."
Life after TB: A Review of Post-TB Lung Diseases

Neranjan Dissanayake Speaker Sri Lanka
Q&A

Ballroom 3, Lower Ground Floor

22 November 2026, Sunday

We use cookies